Daxor (NASDAQ:DXR) used its presentation at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 to outline its focus on blood volume analysis and the company’s commercialization ...
Daxor Corporation has announced a multicenter study published in the Journal of Cardiac Failure, revealing important findings about heart failure treatment using their Blood Volume Analysis (BVA) ...
Daxor Corporation(Nasdaq: DXR), the global leader in blood volume measurement technology, today announces its participation ...
Hemodilution from increased circulating plasma volumes could explain why obese men with prostate cancer have lower serum PSA levels than non-obese men with the malignancy, according to researchers. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results